Difference between revisions of "Part:BBa K1694024"
(23 intermediate revisions by 8 users not shown) | |||
Line 3: | Line 3: | ||
<h1>'''Introduction:'''</h1> | <h1>'''Introduction:'''</h1> | ||
− | [[File:EGFRHALF.png|600px|thumb|center|Pcons+B0034+Lpp-OmpA-N+scFv(Anti-EGFR) ]] | + | [[File:EGFRHALF.png|600px|thumb|center|'''Fig.1''' Pcons+B0034+Lpp-OmpA-N+scFv(Anti-EGFR) ]] |
− | By ligating the constitutive promoter (BBa_J23101), strong ribosome binding site (BBa_B0034) and Lpp-OmpA | + | By ligating the constitutive promoter (BBa_J23101), strong ribosome binding site (BBa_B0034) and Lpp-OmpA |
− | < | + | <html><a href="https://parts.igem.org/Part:BBa_K1694002">(BBa_K1694002)</a> |
− | + | </html> | |
− | < | + | connected to Anti-EGFR |
− | + | <html><a href="https://parts.igem.org/Part:BBa_K1694004">(BBa_K1694004)</a></html> , we were able to display the Anti-EGFR on the E. coli outer membrane continuously. | |
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<br> | <br> | ||
<br> | <br> | ||
+ | This year we want to create a customized platform, so we generated two libraries, Pcon+RBS+OmpA-scFv and Pcons+RBS+Fluorescence+Ter. From these libraries, we can select one plasmid per library to cotransform into the E. coli. Therefore, our customers can choose any scfv and any fluorescent protein. Our team will then co-transform the two plasmids, which help us tailor our product to satisfy the wishes of our customers. | ||
+ | <html> | ||
+ | Introduction of basic parts: | ||
<br> | <br> | ||
− | < | + | <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694002"> Lpp-OmpA-N</a><br> |
− | <br> | + | <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694004"> Anti-EGFR </a><br> |
− | + | </html> | |
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | |||
− | < | + | <h1>'''Experiment:'''</h1> |
− | [[File: | + | '''1.Cloning''' |
− | [[File: | + | [[File:PROCPCR.png|200px|thumb|left|'''Fig.2''' The PCR result of the Pcons+B0034+Lpp-OmpA-N+scFv. The DNA sequence length is around 1100~1300 bp, so the PCR products should appear at 1300~1500 bp.]] |
+ | |||
+ | After assemble the DNA sequences from the basic parts, we recombined each Pcons+RBS+Lpp-OmpA-N+scFv gene to PSB1C3 backbones and conducted a PCR experiment to check the size of each part. The DNA sequence length of these parts is around 1100~1300 bp. In this PCR experiment, the scFv products size should be near at 1300~1500 bp. The '''Fig.2''' showed the correct size of the scFv, and proved that we successful ligated the scFv sequence onto an ideal backbone. | ||
+ | |||
+ | <div style="display: block; height: 400pt;"> | ||
+ | [[File:PROCplate.png|600px|thumb|center|'''Fig.3''' Pcons+B0034+Lpp-OmpA-N+scFv(anti-EGFR)]] | ||
</div> | </div> | ||
− | + | ||
+ | '''2.Cell staining''' | ||
+ | |||
+ | After cloning the part of anti-EGFR, we were able to cotransform anti-EGFR with different fluorescent protein into our ''E. coli''. <br> | ||
+ | The next step was to prove that our co-transformed product has successfully displayed scFv of anti-EGFR and expressed fluorescent protein. | ||
<br> | <br> | ||
− | + | To verify this, we conducted the cell staining experiment by using cotransformed ''E. coli'' to detect the EGFR on the cancer cell line. | |
− | + | ||
<br> | <br> | ||
− | |||
<br> | <br> | ||
− | |||
<br> | <br> | ||
− | + | [[File:Co3.png|400px|thumb|left|'''Fig.4''' As shown in the results, there were no red fluorescent ''E. colis'' bound on the cell’s surface because of the lack of specific-binding scFv displayed around the ''E.coli''. ]] | |
− | ''' | + | [[File:EGFPGFPCELLCO.png|400px|thumb|left|'''Fig.5''' There were green fluorescent anti-EGFR ''E. colis'' bound on the cell’s surfaces, which indicated that the anti-EGFR on the surface of ''E. colis'' could successfully detect and bind on the EGFR.]] |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<br> | <br> | ||
− | + | <div style="display: block; height: 520pt;"> | |
− | < | + | [[File:NGFP.png|400px|thumb|left|'''Fig.6''' As shown in the results, there were no green fluorescent ''E. colis'' binding on the cell’s surface because there is no specific scFv displayed around the ''E.coli''. ]] |
− | + | [[File:EGFPRFPCELLCO.png|400px|thumb|left|'''Fig.7''' There were red fluorescent anti-EGFR ''E. colis'' bound on the cell’s surfaces, which indicated that the anti-EGFR displayed by the ''E. coli'' could successfully detect and bind on the EGFR.]] | |
− | + | </div> | |
− | As results,there | + | |
− | + | <h1>'''Modeling'''</h1> | |
− | There | + | |
− | |||
In the modeling part, we discover optimum protein production time by using the genetic algorithm in Matlab. | In the modeling part, we discover optimum protein production time by using the genetic algorithm in Matlab. | ||
<br> | <br> | ||
We want to characterize the actual kinetics of this Hill-function based model that accurately reflects protein production time. | We want to characterize the actual kinetics of this Hill-function based model that accurately reflects protein production time. | ||
<br> | <br> | ||
− | When we have the simulated protein production rate, the graph of protein production versus time can be drawn | + | When we have the simulated protein production rate, the graph of protein production versus time can be drawn. Thus, we get the optimum protein production time |
Compared with the simulated protein production rate of time, our experiment data quite fit the simulation. | Compared with the simulated protein production rate of time, our experiment data quite fit the simulation. | ||
+ | |||
<br> | <br> | ||
+ | <p style="font-size:120%">'''Co-transform (Two plasmids)'''</p> | ||
+ | |||
<br> | <br> | ||
− | From this graph, the protein expression reaches peak after growing about | + | |
− | + | [[File:Anti-EGFR-RFP.jpg|900px|thumb|center|'''Fig.8''' From this graph, the orange curve is the simulated protein expression. The blue curve is our experimental data. | |
+ | By comparing the orange curve and the blue curve, the blue curve quite fit the simulation. | ||
+ | The orange curve reaches peak after growing about 18 hours. | ||
+ | Thus, we can know that the E. Cotector can have maximum efficiency at this point.]] | ||
+ | |||
<br> | <br> | ||
− | From this graph, the protein expression reaches peak after growing about | + | |
− | + | [[File:anti-EGFR-GFP.jpg|900px|thumb|center|'''Fig.9''' From this graph, the orange curve is the simulated protein expression. The blue curve is our experimental data. | |
+ | By comparing the orange curve and the blue curve, the blue curve quite fit the simulation. | ||
+ | The orange curve reaches peak after growing about 16 hours. | ||
+ | Thus, we can know that the E. Cotector can have maximum efficiency at this point.]] | ||
+ | |||
<br> | <br> | ||
− | From this graph, the protein expression reaches peak after growing about | + | [[File:Anti-EGFR-BFP.jpg|900px|thumb|center|'''Fig.10''' From this graph, the orange curve is the simulated protein expression. The blue curve is our experimental data. |
− | + | By comparing the orange curve and the blue curve, the blue curve quite fit the simulation. | |
+ | The orange curve reaches peak after growing about 6 hours. | ||
+ | Thus, we can know that the E. Cotector can have maximum efficiency at this point.]] | ||
+ | |||
<br> | <br> | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
Latest revision as of 10:51, 22 September 2015
Pcons+B0034+Lpp-OmpA-N+scFv(Anti-EGFR)
Introduction:
By ligating the constitutive promoter (BBa_J23101), strong ribosome binding site (BBa_B0034) and Lpp-OmpA
(BBa_K1694002)
connected to Anti-EGFR
(BBa_K1694004) , we were able to display the Anti-EGFR on the E. coli outer membrane continuously.
This year we want to create a customized platform, so we generated two libraries, Pcon+RBS+OmpA-scFv and Pcons+RBS+Fluorescence+Ter. From these libraries, we can select one plasmid per library to cotransform into the E. coli. Therefore, our customers can choose any scfv and any fluorescent protein. Our team will then co-transform the two plasmids, which help us tailor our product to satisfy the wishes of our customers.
Introduction of basic parts:
Lpp-OmpA-N
Anti-EGFR
Experiment:
1.Cloning
After assemble the DNA sequences from the basic parts, we recombined each Pcons+RBS+Lpp-OmpA-N+scFv gene to PSB1C3 backbones and conducted a PCR experiment to check the size of each part. The DNA sequence length of these parts is around 1100~1300 bp. In this PCR experiment, the scFv products size should be near at 1300~1500 bp. The Fig.2 showed the correct size of the scFv, and proved that we successful ligated the scFv sequence onto an ideal backbone.
2.Cell staining
After cloning the part of anti-EGFR, we were able to cotransform anti-EGFR with different fluorescent protein into our E. coli.
The next step was to prove that our co-transformed product has successfully displayed scFv of anti-EGFR and expressed fluorescent protein.
To verify this, we conducted the cell staining experiment by using cotransformed E. coli to detect the EGFR on the cancer cell line.
Modeling
In the modeling part, we discover optimum protein production time by using the genetic algorithm in Matlab.
We want to characterize the actual kinetics of this Hill-function based model that accurately reflects protein production time.
When we have the simulated protein production rate, the graph of protein production versus time can be drawn. Thus, we get the optimum protein production time
Compared with the simulated protein production rate of time, our experiment data quite fit the simulation.
Co-transform (Two plasmids)
Usage and Biology
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 7
Illegal NheI site found at 30 - 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 451
- 1000COMPATIBLE WITH RFC[1000]